|4Mar 4, 5:23 PM ET

Limongelli John M 4

4 · Neos Therapeutics, Inc. · Filed Mar 4, 2020

Insider Transaction Report

Form 4
Period: 2020-03-02
Limongelli John M
SVP & General Counsel
Transactions
  • Award

    Common Stock

    2020-03-02+100,000100,000 total
  • Award

    Stock Option (Right to Buy)

    2020-03-02+115,000115,000 total
    Exercise: $1.49Exp: 2030-03-02Common Stock (115,000 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock underlying restricted stock unit grants awarded to the Reporting Person. The restricted stock units will vest in two equal, annual installments beginning on March 2, 2021.
  • [F2]This stock option will vest in four equal, annual installments beginning on March 2, 2021.

Documents

1 file
  • 4
    a4.xmlPrimary

    4